Literature DB >> 18230771

Strides made in red blood cell disorders, but substantial barriers to care remain.

Tracy Hampton.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18230771     DOI： 10.1001/jama.2008.3

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.

Authors:  Elizabeth R Macari; Christopher H Lowrey
Journal:  Blood       Date:  2011-04-04       Impact factor: 22.113

2.  Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.

Authors:  Elizabeth R Macari; Emily K Schaeffer; Rachel J West; Christopher H Lowrey
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

Review 3.  A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Authors:  Gift D Pule; Shaheen Mowla; Nicolas Novitzky; Charles S Wiysonge; Ambroise Wonkam
Journal:  Expert Rev Hematol       Date:  2015-09-01       Impact factor: 2.819
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.